Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4537171 | 0.97 | RAB9A (0.51) | RAB9ANPC1PAX8 | |
| SCHEMBL4536863 | 0.88 | HCRTR1 (0.52) | RAB9ANPC1PAX8HCRTR1HCRTR2 | |
| SCHEMBL4537598 | 0.85 | ALDH1A1 (0.52) | NPC1 | |
| SCHEMBL4538118 | 0.85 | RAB9A (0.49) | RAB9ANPC1PAX8HCRTR1HCRTR2 | |
| SCHEMBL4542922 | 0.84 | RAB9A (0.49) | RAB9ANPC1PAX8HCRTR1HCRTR2 | |
| SCHEMBL4541160 | 0.83 | CYP19A1 (0.51) | NPC1 | |
| SCHEMBL4542327 | 0.82 | DRD2 (0.50) | RAB9ADRD2 | |
| SCHEMBL4541692 | 0.82 | RAB9A (0.47) | RAB9ANPC1DRD2DRD3HTR2B | |
| SCHEMBL4539820 | 0.81 | RAB9A (0.67) | RAB9ANPC1PAX8HCRTR1HCRTR2 | |
| SCHEMBL4537168 | 0.81 | RAB9A (0.47) | RAB9ANPC1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009070497-A1 | SEH AND 11 β-HSD1 INHIBITORS AND THEIR USE | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-04 | — | — | WO | disclosed |